SAGAPHARM
The computed 12-month bankruptcy probability of SAGAPHARM is 0.8% (low). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 6 yrs |
| Locations | 1 |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 10-07-2025 | 2025-00261159 |
| 31-12-2023 | micro | 30-08-2024 | 2024-00429503 |
| 31-12-2022 | micro | 29-06-2023 | 2023-00183293 |
| 31-12-2021 | micro | 31-08-2022 | 2022-20405750 |
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Christophe REMONCurrent Company auditor |
- | 16-12-2025 → present |
| NACE primary | Handel in eigen onroerend goed(68110) |
| Legal form | Private limited company(610) |
| Incorporation | 17-06-2020 |
| Status | Active |
| Postal code | 4217 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 61028D0020/00K000 | Wallonia | 2,398 m² | 1 · 161 m² | 11.1 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-12-2025 Capital increase of €314,800
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 314800,
"currency": "EUR",
"after_eur": null,
"delta_eur": 314800,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-12-16",
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u2019augmenter les apports disponibles en soci\u00E9t\u00E9, \u00E0 concurrence de trois cent quatorze mille huit cents euros (314.800 EUR), par la cr\u00E9ation de mille cinq cent septante-quatre (1.574) nouvelles actions.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0748.644.218",
"name_full": "SAGAPHARM",
"legal_form": "SRL"
}
}19-06-2020 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "4217 H\u00E9ron, Rue de la Gare 10",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1972-12-10",
"name": "LUCAS Sandrine Elisabeth Jacqueline",
"niss": null,
"address": "4217 H\u00E9ron, rue de la Gare, 10"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 20000,
"holder_person_name": "LUCAS Sandrine Elisabeth Jacqueline",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 20000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 20000,
"subject_company": {
"kbo": "0748.644.218",
"name_full": "SAGAPHARM",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2020-06-16",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | SAGAPHARM |